HL18 Jan 2022 12:17
finally got this fro HL
"Thank you for getting in touch, I apologise for the delay in my response to your messages regarding Tiziana Life Sciences.
Following the delisting from AIM, the shares commenced trading on NASDAQ. Unfortunately however, the NASDAQ listed version was not crestable. CREST is a UK-based Central Securities Depository that holds UK equities and UK gilts as well as Irish equities and other international securities. CREST allows shareholders and bondholders to hold assets in a dematerialised stock, i.e. electronic form, rather than holding physical share certificates.
If a stock doesn't settle within this system, we're not able to offer it for investment on our platform.
In order to allow clients to trade their shares in Tiziana Life Sciences, we had to transfer the stock to our global custodian HSBC. Unfortunately, we are only able to execute trades for stock held with HSBC over the telephone and additional charges from HSBC would also apply. Our secure message on 17 September 2021 provided more information on this. As it is only possible to trade over the phone, there is no live price feed for the stock.
However, the NASDAQ listed shares have now become crestable, meaning that we will now move them back from HSBC. This will allow the shares to be traded with us as normal at our standard dealing charges and the NASDAQ line of stock will also then show on your portfolio.
I'm afraid you'll be unable to trade your shares whilst the transfer back from HSBC is taking place and unfortunately, there is no exact timeframe we can provide for when we expect this to complete. However, our Corporate Actions team will send out correspondence to all shareholders as soon as we have any updates we can provide.
I appreciate that this is frustrating and I apologise for any inconvenience that this may be causing you but I hope this explains the current position. If you have any further questions, please do not hesitate to get back to me.
Kind regards,
Harry Hoare
Hargreaves Lansdown"